Page 161 - Abstract Book KONIKA 18
P. 161

Emergency & Pediatric Intensive Care

                                              P-EPIC-003
                           Venomous Snake Bite in Children: A Case Report

                               Ernie Yantho, Dewi Ratih, Yusrina Istanti, Moh Supriatna
                 Department of Child Health, Faculty of Medicine Universitas Diponegoro/Dr. Kariadi General Hospital,
                                        Semarang, Central Java, Indonesia
                                               Abstract
            Background Snakebite envenoming has been categorized as one of the neglected tropical disease in many
            tropical countries including Indonesia. In pediatric population there was still no standardized guideline
            of snakebite management as it was tailored individually based on clinical profile and snake species.
            Objective To demonstrate the clinical course and management of snakebite envenoming. Case A three years
            old girl was referred to our hospital with diagnosis of snakebite. She was referred with altered consciousness
            and history of returned of spontaneous circulation after cardiopulmonary resuscitation. At previous hospital,
            she had been given total 6 vials of antivenom infusion. After 48 hours, swelling of left arm extended to left
            thoracoabdominal area without bleeding and signs of compartment syndrome¬. Laboratory tests result were
            normocytic normochromic anemia (hemoglobin 9.7), leukocytosis (22.800), thrombocytopenia (16.000),
            high d-dimer (22.090), low fibrinogen (86) and hyponatremia (119). She was diagnosed with snakebite
            envenoming grade 3 with DIC score 7. She was given antivenom 6 vials every 12 hours with supportive
            therapies (antibiotic prophylaxis, low dose corticosteroid and platelet transfusion). Swelling had progressed
            rapidly so antivenom dose was increased to 8 vials every 12 hours. On day 3 admission, swelling had reduced
            with DIC score decreased to 3 then antivenom was tapered off. Total additional 24 ampoules of antivenom
            were administered to this patient.  Conclusion Early optimal antivenom administration seemed to improve
            clinical course and reduce complication of snakebite envenoming. We recommend antivenom administration
            dose tailored based on clinical profile.
                                   Keywords: snakebites; envenoming; antivenom


                                              P-EPIC-004
                  Clinical Characteristics and Outcomes of Pediatric Severe COVID-19
                          at Mohammad Hoesin General Hospital Palembang

                         Nurmega Kurnia Saputri, Indra Saputra, Desti Handayani, Silvia Triratna
              Department of Child Health, Faculty of Medicine Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital,
                                      Palembang, South Sumatera, Indonesia

                                               Abstract
            Background Data on severe COVID-19 in the pediatric population remains limited. Early diagnosis of
            COVID-19 is difficult due to various clinical manifestations and commonly resemble other diseases.
            Differences in patient characteristics among places may associate with the outcome. Objective To identify
            the clinical characteristics and outcome of children with severe COVID-19 at PICU Mohammad Hoesin
            General Hospital Palembang. Methods The medical records of 40 patients with suspected severe COVID-19
            since June 2020 until June 2021 were reviewed. Inclusion criteria were children one month until 18
            years old, suspected COVID-19 based on clinical manifestations, laboratory and radiologic findings.
            Results Fourteen of 40 patients with positive PCR nasal swab had median (range) age 2(1-5) years old,
            and 10/14 were male. On admission, 14/14 had shortness of breath, flu-like symptom 8/14, decreased
            consciousness 8/14, fever 6/14 and seizure 3/14. Laboratory results showed an increase of C-reactive
            protein (CRP) in 10/14 patients, leukocytosis 6/14, leukopenia 1/14 and lymphopenia 1/14. Pneumonia
            was demonstrated on 13/14 chest radiographs. Comorbidity findings were neurological disease 8/14, lung
            tuberculosis 2/14, autoimmune disease 1/14 and malignancy 1/14. Mechanical ventilation was used in 9/14,
            and non-invasive ventilation was in 5/14 patients. After completing the follow-up period, 9/14 patients
            with comorbid factors died, and seven required mechanical ventilation. Conclusion Severe COVID-19 was
            found predominantly in male, with sign shortness of breath on admission, increasing CRP, pneumonia on
            radiograph, and mortality increased with comorbid factors.
                                    Keywords: severe COVID-19; pediatric; ICU





                                           KONIKA XVIII Abstract Book                                                                     113
   156   157   158   159   160   161   162   163   164   165   166